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Abstract
Viral-vector mediated gene transfer to cerebellar Purkinje neurons in vivo is a promising avenue for gene therapy of
cerebellar ataxias and for genetic manipulation in functional studies of animal models of cerebellar disease. Here, we report
the results of experiments designed to identify efficient methods for viral transduction of adult murine Purkinje neurons
in vivo. For these analyses, several lentiviral and an adeno-associated virus (AAV), serotype 1, vector with various promoter
combinations were generated and compared for in situ transduction efficiency, assayed by fluorescent reporter protein
expression in Purkinje neurons. Additional experiments were also conducted to identify the optimal experimental strategy
for co-expression of two proteins in individual Purkinje neurons. Of the viruses tested, AAV1 with a CAG promoter exhibited
the highest specificity for Purkinje neurons. To deliver two proteins to the same Purkinje neuron, several methods were
tested, including: an internal ribosome entry site (IRES), a 2A sequence, a dual promoter vector, and co-injection of two
viruses. Efficient expression of both proteins in the same Purkinje neuron was only achieved by co-injecting two AAV1-CAG
viruses. We found that use of an AAV1-CAG virus outperformed similar lentivirus vectors and that co-injection of two AAV1-
CAG viruses could be used to efficiently deliver two proteins to the same Purkinje neuron in adult mice. AAV1 with a CAG
promoter is highly efficient and selective at transducing adult cerebellar Purkinje neurons and two AAV-CAG viruses can be
used to efficiently express two proteins in the same neuron in vivo.
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Introduction
The cerebellum functions as an important regulator of body
movement and coordination, and, as such, disorders of the
cerebellum typically result in ataxia, a clinical symptom charac-
terized by lack of coordination and gait disturbances. As the sole
output of the cerebellar cortex, Purkinje neurons are critical for
cerebellar information processing [1] and, therefore, may provide
an ideal target for therapies designed to restore or improve
cerebellar function. Cerebellar disease can be acquired (e.g.
ethanol, drugs, stroke, or trauma) or inherited [2]. The inherited
cerebellar ataxias, many of which have known genetic bases, may
be particularly amenable to treatments based on gene transfer.
Studies of cerebellar function and pathophysiology would also
benefit from methods to genetically manipulate Purkinje neurons
in adult model organisms. Viral vectors provide a promising gene
delivery system in both basic research and gene therapy.
For some gene transfer applications, it is desirable to express
more than one protein in a given cell. Such situations may include
transfer of multiple genes that cooperate functionally or transfer of
a gene of interest with a fluorescent reporter gene for easy
identification of transduced cells in living systems. A number of
strategies have been used successfully to co-express multiple
transgenes in the same cell using viral vectors, including internal
ribosome entry sites (IRES) elements [3], 2A peptides [4], dual
internal promoters [5], and co-infection with multiple viral vectors
[6]. One of the most commonly used approaches has been
insertion of an IRES element between two transgenes, which
enables production of two polypeptides from a single transcript
[7]. More recently, however, 2A peptides have gained in
popularity due to their small size (,18–22 amino acids) and
ability to produce discrete proteins in essentially equimolar
quantities [8]. Insertion of a 2A sequence between two genes
results in ribosomal ‘skipping’ during translation [9], such that the
ribosome continues downstream without formation of a peptide
bond.
The goal of this study was to develop a viral vector system for
efficient and selective virally transduced gene expression in adult
murine Purkinje neurons in vivo and to optimize for co-expression
of two transgenes. As an example, we used Fibroblast Growth
Factor 14 (FGF14), which is highly expressed in wild type
cerebellar Purkinje neurons [10,11] and in which a mutation
causes Spinocerebellar ataxia, type 27 (SCA27) in humans [12–
15]. We tested four lentiviral and one AAV construct with various
promoter and fluorescent reporter gene combinations and found
optimal expression in adult murine Purkinje neurons in vivo using
AAV serotype 1 (AAV1) constructs containing a modified chicken
b-actin promoter with the CMV-IE enhancer (CAG) [16].
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Co-expression of FGF14 with a fluorescent reporter gene in the
same neuron in adult mice was only achieved by co-injecting two




This study was performed in accordance with guidelines from
the NIH Guide for the Care and Use of Laboratory Animals, and
all protocols involving animals were approved by the Washington
University Animal Studies Committee. All surgery was performed
under isofluorane gas or ketamine/xylazine anesthesia, and every
effort was made to minimize pain and suffering.
Mice
Adult (2–4 months) wild type C57BL/6, Fgf142/2 [17], and
L7/pcp2-GFP [18] mice were maintained in accordance with
guidelines from the NIH Guide for the Care and Use of
Laboratory Animals, and all protocols involving animals were
approved by the Washington University Animal Studies Commit-
tee. Genotypes were confirmed by PCR analysis.
Plasmid constructs
Lentiviral vectors used in this study were constructed from
third-generation self-inactivating (SIN) lentiviral transfer vectors.
The plasmid constructs for lentiviral vectors MND-GFP,
PGK-GFP, and UBC-Venus have been described previously
[19]. MSCV-GFP (SIN-MU3-EGFP-W), in which eGFP expres-
sion is controlled by a murine stem cell virus (MSCV) LTR [20],
was provided by R. Hawley (George Washington University).
AAV-IRES-GFP (pTR-UF-12.1) has been described previously
[21].
Lentivirus construct for MND-GFP (pCCL-cppt-MNDU3-
GFP) expresses eGFP under control of a modified Moloney
murine leukemia virus (MoMuLV) LTR with myeloproliferative
sarcoma virus enhancer, deleted negative control region, and
substituted Dl587rev primer-binding site [22,23]. PGK-GFP
(pRRLsinPGKGFPppt), contains a human phosphoglycerate
kinase (PGK) promoter followed by eGFP [24]. In UBC-Venus
(FCIV.FM1), Venus (a yellow fluorescent protein) expression is
controlled by a ubiquitin C promoter and internal ribosome entry
site (IRES).
The lentiviral vector MND-tdTomato (pMRT-tdTomato-
shRNAmir) was constructed by linearizing the lentiviral MND
vector (pCCL-cppt-MNDU3) with EcoRI and SalI and inserting a
new polylinker containing NheI and PacI restriction enzyme sites.
The polylinker was synthesized as single-stranded DNA oligonu-
cleotides by IDT (Coralville, IA). Oligonucleotides were annealed
together prior to insertion into MND vector. The DNA sequence
of the new polylinker in the MND vector (pMND-NP) was 59-
GAATTGGCTAGCGTTAACGGATCCGCTTAATTAAGT-
ACGCGTCCCGGGGTCGAC-39, which corresponds to the
restriction enzyme sequence of ClaI-NheI-HpaI-BamHI-PacI-
MluI-SmaI-SalI-BclI-KpnI, which maintained the SalI restriction
site but destroyed the EcoRI site. pMND-NP was then linearized
Figure 1. Schematic representation of lentiviral constructs. A–B. Schematic of the lentiviral constructs used in this study. Arrows represent
mammalian transcriptional start sites. In all vectors, the 39-LTR contains a deletion in the U3 region which renders the virus self-inactivating (SIN 39-
UTR) and replication incompetent. A. The MND-tdTomato lentiviral vector contains a microRNA (miR30) and chloramphenicol resistance gene (CMR)
in the 39-UTR of the tdTomato fluorescent reporter gene. B. The internal promoters are MND, modified MoMuLV LTR containing myeloproliferative
sarcoma virus enhancer; MSCV, murine stem cell virus LTR; UBC, Ubiquitin C promoter; and PGK, human phosphoglyercerate kinase promoter. Y:
packaging signal; RRE, REV response element; cPPT, central polypurine tract; EGFP, enhanced green fluorescent protein; IRES, internal ribosome entry
site; WPRE, woodchuck hepatitis virus posttranscriptional regulatory element; LTR, long terminal repeat.
doi:10.1371/journal.pone.0104062.g001
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by digesting with NheI and PacI and a tdTomato-shRNAmir-
CMR (chloramphenicol resistance gene) cassette was inserted after
being cut out with the same enzymes. The insert was prepared
from pGEM-pPRIME-CMV, which was made by moving the
CMV-GFP-shRNAmir-CMR cassette from pPRIME-CMV-GFP
vector into pGEM vector and replacing the GFP fluorophore with
tdTomato. pPRIME-CMV-GFP was a gift from S. Elledge
(Harvard University) and contains an shRNAmir in the 39-UTR
of the GFP fluorescent reporter gene. The shRNAmir is an
shRNA sense-loop-antisense sequence with 19 nt loop embedded
in a mir30 microRNA context [25] (Figure 1A). The final MND-
tdTomato (pMRT-tdTomato-shRNAmir) vector consisted of the
MND promoter followed by tdTomato fluorescent reporter gene,
shRNAmir, and CMR. The 21-mer shRNA sequence is 59-
GCCATTGGAAGTTGCCATGTA-39, and targets murine
Fgf14. The insert was verified by sequencing before packaging
into virus.
AAV-IRES-GFP (pTR-UF-12.1) [21] consists of a CMV early
enhancer with chicken b-actin (CAG) promoter followed by a
simian virus 40 (SV40) intron, internal ribosome entry site (IRES),
eGFP, SV40 polyadenylation (polyA) site and bovine growth
hormone (BGH) polyA site. To generate, AAV-GFP without
IRES, AAV-CAG-hFGF14B-P2A-GFP (see below) was digested
with NsiI and MluI to remove the hFGF14B-P2A-GFP cassette.
GFP was amplified from pQBI-fC2 (Quantum Biotechnology Inc.,
Montreal, Canada) to add a 59-NsiI restriction site and Kozak
consensus sequence upstream of the initiation methionine and a
downstream 39-Mlu and translational stop codon. PCR fragment
was digested with NsiI and MluI and inserted into the digested
AAV vector. The resulting construct contained the CAG promoter
followed by the SV40 intron, GFP, SV40 polyA, and BGH polyA.
The plasmid was verified by sequencing and was transfected into
CHL1610 cells to confirm expression of the GFP reporter gene
before viral particle packaging.
To construct AAV-FGF14B-GFP (fusion), AAV-IRES-GFP was
digested with NotI to remove GFP, and an MluI linker with NotI
sticky ends was inserted in its place (IDT, Coralville, IA). The
AAV plasmid without GFP was then cut with EcoRV (blunt) and
MluI to remove the IRES. The hFGF14B-GFP insert was
prepared by digestion of pQBI-hFGF14B-GFP plasmid [26] with
ApaI followed by blunting with Klenow. Blunted plasmid DNA
was then cut with MluI, and the hFGF14B-GFP fragment was gel
purified. The hFGF14B-GFP insert with a 59-blunt end and 39-
MluI sticky end was then ligated into the AAV plasmid with blunt
and MluI sticky end sites. The final AAV-hFGF14B-GFP
construct consisted of the CAG promoter followed by the SV40
intron, hFGF14B-GFP fusion, SV40 polyA, and BGH polyA.
Before viral packaging, the insert was verified by sequencing, and
fluorescent reporter expression was verified by transfection into
CHL1610 cells.
To create AAV-FGF14B-IRES-tdTomato, AAV-IRES-tdTo-
mato was used. AAV-IRES-tdTomato was created from AAV-
IRES-GFP (pTR-UF-12.1) by replacing the GFP with tdTomato.
AAV-IRES-tdTomato contains the CAG promoter followed by
the SV40 intron, IRES, tdTomato, SV40 polyA, and BGH polyA.
hFGF14B was amplified by PCR from pQBI-hFGF14B-GFP to
add a 59-SpeI restriction site and 39 translational stop codon and
NsiI restriction site. PCR fragment was digested with SpeI and
NsiI and inserted into AAV-IRES-tdTomato also digested with
SpeI and NsiI. The resulting AAV-hFGF14B-IRES-tdTomato
construct contained the CAG promoter followed by the SV40
intron, hFGF14B, IRES, tdTomato, SV40 polyA, and BGH-
polyA. The insert was verified by sequencing, and plasmid DNA
was transfected into CHL1610 cells to confirm expression of the
tdTomato fluorescent reporter prior to viral packaging.
To generate P2A constructs, oligonucleotides containing the
P2A sequence with 59-NotI and 39-NheI sticky ends were
synthesized (IDT, Coralville, IA). A Gly-Ser-Gly linker amino
acid sequence was also added at the 59 end. The following GSG-
P2A oligonucleotide sequence was used: 59-GGAAGCGGAGC-
TACTAACTTCAGCCTGCTGAAGCAGGCTGGAGACGT-
GGAGGAGAACCCTGGACCT-39 [27], which corresponds to
the peptide sequence: GSG-ATNFSLLKQAGDVEENPGNP, with
N representing the point of cleavage. AAV-hFGF14B-GFP was cut
with NotI and NheI to open the vector between the hFGF14B and
GFP sequences, and the annealed P2A oligonucleotide was
inserted. AAV-hFGF14B-P2A-GFP plasmid contained the CAG
promoter followed by the SV40 intron, hFGF14B, P2A, GFP,
SV40 polyA, and BGH polyA. The P2A insert was verified by
sequencing. Before viral particle generation, GFP fluorescence was
confirmed by transfection of plasmid DNA into CHL1610 cells,
and GFP cleavage was validated by Western blotting.









Lv-PGK-GFP 2 + WM
Lv-UBC-Venus 2 - GCL
Lv-MSCV-GFP 2 - BG
Lv-MND-GFP 2 - BG, WM
Lv-MND-tdTomato 6 - BG, WM
AAV1-CAG-GFP 13 ++ ML
AAV1-CAG-FGF14B-GFP 6 ++ ML
AAV1-CAG-FGF14B-IRES-tdTomato 16 ++ ML
AAV1-CAG-FGF14B-P2A-GFP 2 ++ ML
AAV1-CAG-FGF14A-PGK-GFP 4 ++ CAG-FGF14 in ML,
PGK-GFP in BG
a-,#1 Purkinje neurons transduced per 20x field; +, #5 Purkinje neurons transduced per 20x field; ++, .5 Purkinje neurons transduced per 20x field.
bCells transduced based on cell morphology and cerebellar region. GCL, granule cell layer; BG, Bergmann glia; WM, white matter; ML, molecular layer.
doi:10.1371/journal.pone.0104062.t001
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To generate dual promoter AAV plasmids, the IRES-GFP
cassette was first removed from the AAV-IRES-GFP (pTR-UF-
12.1) plasmid by cutting with NotI to remove the GFP and
blunting the ends with Klenow. AAV-IRES linearized plasmid was
then cut with EcoRV to remove the IRES and create a blunt site
following the CAG promoter. Blunt ends were then ligated
together to generate an AAV-CAG-empty plasmid consisting of
the CAG promoter followed by the SV40 intron, SV40 polyA, and
BGH-polyA. The AAV-CAG-empty vector was then digested with
SalI to linearize the plasmid between the SV40 polyA and BGH-
polyA sequences. Digested SalI sticky ends were dephosphorylated
with calf intestinal phosphatase (CIP) followed by column
purification (QIAquick PCR purification kit, Qiagen). The
PGK-GFP insert was prepared from pRRLsinPGKGFPppt by
digesting with XhoI and SalI and was directly ligated into The
AAV-CAG-empty vector digested with SalI to create AAV-CAG-
empty-PGK-GFP. Correct orientation of PGK-GFP insert was
verified by restriction digest. AAV-CAG-empty-PGK-GFP was
then cut with NsiI and ClaI to open the vector between the SV40
intron and SV40 polyA. mFGF14A insert was prepared by PCR
from pQBI-mFGF14A-GFP [26] to add a 59-NsiI restriction site
and Kozak consensus sequence upstream of the initiation
methionine and 39-ClaI restriction site and a translational stop
codon. The mFGF14A PCR product was inserted into pCR2.1-
TOPO-TA vector (Invitrogen), and then digested with NsiI and
ClaI. The mFGF14A fragment was then inserted into AAV-CAG-
empty-PGK-GFP vector to make the AAV-CAG-mFGF14A-
PGK-GFP dual promoter vector. The final plasmid construct thus
contained the CAG promoter followed by the SV40 intron,
mFGF14A and SV40 polyA and the PGK promoter followed by
GFP and BGH polyA. Inserts were verified by sequencing, and
GFP expression was verified by transfection into CHL1610 cells.
Lentiviral vector production
Lentiviral viral vectors were generated by the Hope Center
Viral Vectors Core as described previously [28]. Briefly, the
packaging cell line, HEK293T was maintained in Dulbecco’s
modified Eagles medium (DMEM), supplemented with 10% fetal
bovine serum (FBS), 100 units/ml penicillin, 100 mg/ml strepto-
mycin in a 37uC incubator with 5% CO2. HEK293T cells were
plated at 30–40% confluence 24 h before transfection (70–80%
confluence when transfected). Ten mg of lentiviral vector with the
appropriate insert, 5.8 mg of pMD-Lg, 3.1 mg of pCMV-G, and
2.5 mg of RSV-REV were co-transfected into 293T cells using the
calcium phosphate precipitation procedure. Six hours after
transfection, the medium was replaced with the complete medium
containing 6 mM sodium butyrate. Culture supernatant was
collected 42 h after transfection. The supernatant was passed
through a 0.45 mm filter, concentrated by ultracentrifugation
through a 20% sucrose cushion, and stored at 280uC until use.
Vector titers were determined by transduction of HT1080 cells
and assayed for reporter expression using flow cytometry. The
lentiviral titers used in this study are as follows: PGK-
GFP=16108 TU/ml; UBC-Venus = 5.46107 TU/ml; MND-
GFP=4.76109 TU/ml; MSCV-GFP= 1.56108 TU/ml; MND-
tdTomato-sh4 (referred to as MND-tdTomato) = 1.86109 TU/ml.
AAV vector production
AAV viral vectors were generated by the Hope Center Viral
Vectors Core as described previously [29]. Briefly, HEK293 cells,
maintained as above were plated at 30–40% confluence in
CellSTACS (Corning, Lowell, MA) 24 h before transfection (70–
80% confluence when transfection). 1.8 mg helper plasmid (e.g.
pXYZ1 for AAV1) and 0.6 mg rAAV transfer plasmid containing
the gene of interest were co-transfected using the calcium
phosphate precipitation procedure. Cells were incubated at 37uC
for 3 days before harvesting. Cells were lysed by three freeze/thaw
cycles. The cell lysate was treated with 50 U/ml of Benzonaze
followed by iodixanol gradient centrifugation. The iodixanol
gradient fraction was further purified by column chromatography
using HiTrap Q columns (GE Healthcare) for AAV1. The eluate
was concentrated with Vivaspin 20 100K concentrator (Sartorius
Stedim, Bohemia, NY). Viral titer was determined by dot blot
assay. In the dot blot assay, AAV viral prep was treated with
DNaseI to remove DNA that was not in the viral particle. After
inactivating the DNaseI, vector genome was released from viral
particles by digestion with proteinase K. DNA was extracted,
denatured, and transferred to nylon membranes. A serially diluted
AAV plasmid with known copy number was also transferred to
membrane. A 32P-labeled oligonucleotide probe containing the
sequence in the AAV vector was hybridized to membranes and
signal was detected by exposure to X-ray film. Titer was calculated
by comparison with standard curve of AAV plasmid with known
copy number. Titers of AAV viruses used in this study were as
follows: AAV1-CAG-GFP 7.161012 vg/ml (viral genomes per ml);
AAV1-CAG-FGF14B-GFP= 1.761013 vg/ml; AAV1-CAG-
FGF14B-IRES-tdtomato = 561012 vg/ml; AAV1-CAG-FGF14B-
P2A-GFP= 561012 vg/ml; and AAV1-dual promoter-CAG-
mFGF14A-PGK-GFP= 161013 vg/ml.
Cell culture, transfection, and western blots
Chinese hamster lung (CHL) 1610 cells [30] were maintained in
RPMI media supplemented with 10% fetal bovine serum (Gibco)
and 100 U/ml penicillin, 100 mg/ml streptomycin, and incubated
at 37uC with 5% CO2. Cells were transfected at 80–90%
confluency using Lipofectamine 2000 (Invitrogen) according to
Figure 2. Patterns of cellular transduction by Lenti-MND-tdTomato. A. Montage of low magnification confocal images of sagittal sections of
wild type mouse cerebellum injected with MND-tdTomato (red) and immunostained for calbindin (green), a marker for Purkinje neurons. A region of
tdTomato expressing cells in the Purkinje and/or molecular layer is visible near the injection site, but the vast majority of tdTomato-expressing cells
are in the white matter (wm). Arrowhead indicates approximate location of injection, where some damage to brain parenchyma can be seen. A’. A
higher magnification image from an adjacent slide illustrating the lack of co-localization of tdTomato-expressing processes and calbindin positive
Purkinje neuron dendrites. B–E. To examine transduction patterns in more detail, MND-tdTomato was injected into L7/pcp2-GFP mouse cerebellum,
and sagittal sections were examined at higher magnification. L7/pcp2-GFP mice express GFP under control of the Purkinje cell specific promoter L7/
pcp2. B, GFP expression is visible in Purkinje neuron somata, dendrites, and axons (ax), which project into the white matter tract (left panel and green,
right panel). tdTomato-expressing somata are located in the white matter tracts and extend short processes (center panel and red, right panel). C.
Purkinje neuron axons (left panel and green, right panel) and processes expressing tdTomato (center panel and red, right panel) do not overlap. D-E.
High magnification images of the Purkinje layer of L7/pcp2-GFP cerebellum injected with MND-tdTomato. D. GFP-expressing Purkinje neuron somata
with characteristic highly branched dendrites (left and green, right panel). Cells expressing tdTomato are located in the Purkinje layer but somata are
smaller and processes are straight and unbranched (center). tdTomato (red) expression pattern does not colocalize with GFP (green) expressing
Purkinje neuron somata or dendrites (right panel). The shape and location of tdTomato expressing cells is consistent with Bergmann glia. E.
Coexpression of GFP (left) and tdTomato (center) in three Purkinje neuron somata (arrowheads, and yellow, right panel). Scale bars: 100 mm (A, B),
50 mm (A’), 25 mm (D, E).
doi:10.1371/journal.pone.0104062.g002
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the manufacturer’s instructions. 5 mg of plasmid DNA was
transfected into cells plated in 60 mm2 dishes. 24 h after
transfection, fluorescence was visualized and photographed in
living cells using a Leica DMIL LED inverted microscope.
Following visualization, cells were washed once with 2 ml ice cold
PBS and lysed in ice cold lysis buffer (20 mM Tris-HCl, 150 mM
NaCl, and 1% NP-40). Protease inhibitor mixture (Protease
Inhibitor Cocktail Set III; Millipore, Bedford, MA) was added
immediately before cell lysis. Cell extracts were collected,
incubated with slow rotation for 15 min at 4uC, and centrifuged
for 10 min at 3000 rpm and 4uC to remove the insoluble fraction.
Protein content was measured using a BCA assay kit (Pierce-
Thermo, Rockford, IL). For Western blots, 50 mM Bond-Breaker
TCEP (Thermo Fisher Scientific, Rockford, IL) was added to cell
lysates and 30 mg of each lysates were loaded into each lane.
Resolved proteins were transferred to PVDF-P membranes
Figure 3. Expression of reporter genes in cerebellar cells transduced with lentiviral vectors under various promoters. Representative
confocal images of sagittal cerebellar sections from mice 7–14 days following intracerebellar injection of lentiviral vectors with indicated promoters.
Dotted lines demarcate the border between cerebellar cortex layers. In low magnification images (B, D, F, G, and J), the line is drawn between
Purkinje and granule layers. In high magnification images (A, C, E, H, and I), two lines are drawn to separate the Purkinje layer from the molecular layer
and granule layer. A. Widespread GFP expression in a cerebellar lobe injected with MND-GFP. B. Single confocal section of MND-GFP transduced
cerebellum at higher magnification showing absence of GFP expression in Purkinje neuron somata (asterisks). C. Low magnification of cerebellum
injected with MSCV-GFP. D. High magnification of cerebellum injected with MSCV-GFP demonstrating GFP expression in small cell bodies in the
Purkinje layer with radial processes extending to the pial surface, characteristic of Bergmann glia. E. Venus expression in a cerebellar lobe injected
with UBC-Venus. F, G. High magnification of UBC-Venus infected cerebellum shows venus expression in multiple small cells in the granule layer (F)
and a single Purkinje neuron (G). H, I. GFP expression in cerebellar lobes of two animals injected with PGK-GFP. Several GFP-expressing Purkinje
neurons are visible in H, whereas most GFP-expressing cells in I are in the white matter, with a single GFP-positive Purkinje neuron. J. High
magnification view of GFP-positive Purkinje neurons from H. Abbreviations: m=molecular layer; p = Purkinje layer; g = granule layer; wm=white
matter. Scale bars, 25 mm (B, D, F, G, J), 100 mm (A, C, E, H, I).
doi:10.1371/journal.pone.0104062.g003
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(Millipore, Bedford, MA) for 1.5 h at 4uC and blocked with 3%
non-fat dry milk (vol/vol) in PBST. Blots were probed with
primary antibody diluted in 0.5% non-fat dry milk (vol/vol) in
PBST for 2 h at room temperature. After washing extensively with
PBST, blots were incubated with secondary antibody diluted in
0.5% non-fat dry milk (vol/vol) in PBST for 1 h at room
temperature. The primary antibodies used for western blotting
were mouse monoclonal anti-GFP (1:1000, NeuroMab, N86/8)
and rabbit polyclonal anti-FGF14 (1:1000). Secondary antibodies
used were goat anti-mouse-HRP or goat anti-rabbit-HRP (both
1:5000, Santa Cruz Biotechnology, Dallas, TX).
Stereotactic injections
Mice were anesthetized with isoflurane gas (2%) or ketamine/
xylazine cocktail (30 mg/ml ketamine and 4 mg/ml xylazine, at a
dose of 1 ml/kg, i.p.) and fixed in a stereotactic frame (David
Kopf, Tujunga, California or Stoelting, Wood Dale, Illinois). For
lentiviral injections, a midline incision was made on the scalp, and
a 2 mm burr hole was made using a dental drill, and a 5 ml Hamilton
syringe was lowered 0.25–0.5 mm below the dural membrane at the
previously determined coordinates. A nanoinjector pump (Stoelting)
was used for infusion of 3–6 ml virus at a rate of 0.1–0.2 ml/
min, after which the needle was left in place for 5–10 min to
ensure complete diffusion of the virus. At the end of the
injection, the incision was closed with a 4–0 nylon suture and
triple antibiotic ointment was applied topically. For some
lentiviral and all AAV injections, the cranium at the desired
coordinates was thinned, and a craniotomy was performed by
using a scalpel to gently lift a small flap of bone away from the
surface of the brain. Virus was loaded into pulled glass pipettes
(outer tip diameter of 18–25 mm) and injected using a
Picospritzer (Parker Hannifin, Mayfield Heights, Ohio). Approx-
imately 1–2 ml of virus was injected over a 5–10 min period.
Following virus injection, incision was closed using surgical
staples. Mice were placed into a warming chamber until
consciousness was fully regained. The sterotaxic coordinates to
target the Purkinje neuron layer of lobule VI were: midline, 1–
2 mm anterior to interparietal-occipital suture (or about 5–
6 mm caudal to bregma) and 0.35 mm below the pial surface.
For each virus, two or more animals were injected per
experiment, and representative images were chosen. The exact
n for each virus condition is given in Table 1. We did not see a
correlation between the viral titer and the ability of the viral
prep to label any cell near the injection site.
Figure 4. MND-tdTomato expression following injection with pulled glass pipette. Confocal images of sagittal cerebellar slices from wild
type mice injected with MND-tdTomato lentivirus. Injections were performed using pulled glass pipettes and a picospritzer (see methods) to
determine if injection technique affected cellular transduction pattern. Dotted lines in A and B represent the border between the Purkinje layer and
granule layer. In C, dotted lines are drawn to separate the Purkinje layer from the molecular layer and granule layer. A. Widespread tdTomato
expression in cells in the granule layer and processes in the molecular layer. B. A few small tdTomato expressing cells are visible in the Purkinje layer,
but the majority of the tdTomato expressing cell bodies are located in the white matter (wm). C. High magnification view of tdTomato expressing
cells with somata in the Purkinje layer show that their processes are relatively straight and unbranched, characteristic of Bergmann glia. m, molecular
layer; p, Purkinje layer; g, granule layer. Scale bars: 100 mm (A, B); 25 mm (C).
doi:10.1371/journal.pone.0104062.g004
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Immunostaining
7–14 days following lentivirus injection or 4–8 weeks following
AAV virus injection, mice were deeply anesthetized with a
ketamine/xylazine cocktail (30 mg/ml ketamine and 4 mg/ml
xylazine, at a dose of 1 ml/kg, i.p.) and transcardially perfused
with 0.9% NaCl and followed by ice-cold fixative, consisting of 1%
formaldehyde freshly prepared from paraformaldehyde powder
[31] in 0.1 M phosphate buffer, pH 7.4. Brains were removed and
post-fixed for one hour in the same fixative at 4uC, followed by
overnight cryoprotection in 30% sucrose in 0.1 M phosphate
buffer at 4uC. Brains were embedded in OCT, and sagittal
cryostat sections of cerebellum (16 mm) were mounted onto slides
and stored at 280uC until processing.
All of the following steps were at room temperature. For
examining fluorescent reporter gene expression without immuno-
staining, slides containing cerebellar sections were rinsed twice in
0.01 M phosphate buffered saline (PBS), pH 7.4 (Sigma, St. Louis,
MO) and coverslips were mounted with Vectashield mounting
medium (Vector Laboratories). For immunostaining, slides were
washed twice with PBS and permeabilized for 20 min in PBS with
0.1% Triton X-100 (vol/vol). Sections were incubated with
blocking solution (PBS plus 10% goat serum) for 1 h, followed
by staining overnight with primary antibodies diluted in PBS with
0.1% Triton X-100 and 0.1% bovine serum albumin. After
washing with PBS, sections were incubated with appropriate goat
secondary antibodies conjugated to Alexa 488 or 594 or 657
(1:400, Invitrogen) diluted in PBS for 1 h. Sections were again
washed with PBS and coverslips were mounted using Vectashield
Hardset mounting medium (Vector Laboratories) and allowed to
dry overnight at 4uC. The following primary antibodies were used:
mouse monoclonal anti-FGF14 (1:1000, NeuroMab, clone N56/
21), mouse monoclonal anti-AnkyrinG (1:1000, NeuroMab, clone
Figure 5. AAV1 transduction of Purkinje neurons and localization of viral delivered FGF14B-GFP. A. Schematic representation of AAV
transfer plasmid constructs for AAV-CAG-GFP and AAV-CAG-FGF14B-GFP. CAG, chicken b-actin promoter with CMV enhancer; in, SV40 intron; pA,
polyadylation site; ITR, inverted terminal repeat. B. Confocal image from a sagittal cerebellar section injected with AAV1-CAG-GFP showing
predominant GFP expression in Purkinje neuron somata and dendrites. Some GFP expressing cell bodies are visible in the granule layer. C, D.
Immunostaining for FGF14 in an Fgf142/2 mouse with intracerebellar injection AAV1-CAG-FGF14B-GFP. C. Low magnification montage of FGF14-
specific immunostaining in an Fgf142/2mouse injected with AAV-CAG-FGF14B-GFP. FGF14 expression is evident in an entire lobe. D. Immunostaining
for FGF14 in an Fgf142/2 mouse injected with AAV-CAG-FGF14B-GFP shows no FGF14 expression in areas distal to the injection (top) whereas areas
near the injection show rescue of FGF14 expression in Purkinje neuron soma and AIS (middle). For comparison, normal FGF14 expression in a wild
type cerebellum is shown at the bottom. Asterisks mark the location of the Purkinje neuron soma and arrows mark the approximate start and end of
the AIS. Arrowheads mark the AIS of FGF14-expressing stellate and basket cells in the molecular layer. Scale bars: 200 mm (C); 25 mm (B, left panels in
D); 5 mm (right panels in D).
doi:10.1371/journal.pone.0104062.g005
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Figure 6. AAV1 delivery of FGF14B-IRES-tdTomato and FGF14B-P2A-GFP results in efficient FGF14 expression but failure of
reporter gene fluorescence. A. Schematic representation of CAG-FGF14B-IRES-tdTomato AAV transfer construct. CAG, chicken b-actin promoter
with CMV enhancer; in, SV40 intron; IRES, internal ribosome entry site; pA, polyadenylation site; ITR, inverted terminal repeat. B. CAG-FGF14B-IRES-
tdTomato transfected into CHL1610 cells produces a diffuse cytoplasmic tdTomato expression pattern. C. Confocal image from an Fgf142/2 mouse
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N106/36), and mouse monoclonal anti-GFP (1:1000, NeuroMab,
clone N86/38). The FGF14 antibody has been validated using
Fgf142/2 mice [10,11]. The AnkyrinG antibody is a validated
NeuroMab antibody and in our experience it gives very specific
staining of the AIS. The GFP antibody is a validated NeuroMab
antibody and does not give background staining with wild type
mouse tissue. The Images were captured using a confocal laser
scanning microscope (Olympus Fluoview-500) using a 20x or 60x
oil-immersion objective. Sequential acquisition of multiple chan-
nels was used, and z-stacks were collected at 0.5 mm steps. Image
stacks were converted into maximum intensity z-projections using
ImageJ software (NIH).
Results
Patterns of cellular transduction by lentiviral vector with
MND promoter
To explore methods to efficiently transduce Purkinje neurons
in vivo, third generation self-inactivating (SIN) vectors with
various combinations of promoters and fluorescent reporters genes
were constructed as diagrammed in Figure 1A–B. Initial exper-
iments to target Purkinje neurons in vivo used a lentiviral
construct expressing tdTomato under control of the MND
promoter (modified Moloney murine leukemia virus (MoMuLV)
LTR with myeloproliferative sarcoma virus enhancer) (Figure 1A).
This construct also contains an shRNA in the 39-UTR of the
tdTomato gene, but only viral transduction was evaluated in these
experiments. MND-tdTomato viral particles were injected directly
into wild type mouse cerebellum, and sections were immuno-
stained with an anti-calbindin antibody to label Purkinje neurons.
Consistent with previous reports [32], calbindin immunoreactivity
was evident in Purkinje neuron somata (Figure 2A). Examination
of sagittal cerebellar sections at low magnification revealed a
moderate amount of damage to the brain parenchyma near the
injection site (Figure 2A, arrowhead). Bright tdTomato expression
was localized mainly to cerebellar white matter and spread far
from the injection site into adjacent lobes (Figure 2A, Table 1).
The Purkinje and/or molecular layers exhibited tdTomato
expression only in a small region. A higher magnification image
of this region in an adjacent slide (Figure 2A’) illustrates a lack of
co-localization of tdTomato-expressing and calbindin-expressing
processes.
To investigate the cell types transduced with MND-tdTomato
in more detail, lentiviral particles were injected into L7/pcp2-GFP
mice, which express GFP under control of the Purkinje cell specific
promoter, L7/pcp2 [18]. Purkinje neuron cell bodies, dendrites
and axons are clearly labeled with GFP in L7/pcp2 mice
(Figure 2B–E). In cerebellar white matter tracts, GFP expression
was visible in Purkinje neuron axons, whereas tdTomato
expression was evident in discrete punctae and short processes
radiating towards the Purkinje layer (Figure 2B). Interestingly,
tdTomato expression in these short processes did not co-localize
with GFP expression in Purkinje neuron axons (Figure 2C).
Together, this suggested that MND-tdTomato transduced cells in
the white matter were myelinating glia and not Purkinje neuron
axons (Table 1). Closer examination of the Purkinje layer revealed
that most of the transduced cells in that region were Bergmann
glia, with small cell bodies in the Purkinje layer and radial
processes extending into the molecular layer (Figure 2D, Table 1).
In rare instances, transduced Purkinje neurons were observed
(Figure 2E, arrowheads).
Comparison of lentiviral vectors with various promoters
To compare promoter activity in adult Purkinje neurons
in vivo, we tested lentiviral constructs expressing EGFP or Venus
fluorescent reporter genes under control of various promoters
(Figure 1B). In addition to the MND promoter described in
Figure 2, the following promoters were tested: MSCV (LTR from
murine stem cell virus); Ubiquitin C (UBC); and PGK (human
phosphoglycerate kinase promoter). Lentiviruses were injected
directly into wild type mouse cerebellum, and specificity of cellular
transduction was determined by cellular morphology and laminar
distribution.
Consistent with previous findings using MND-tdTomato
(Figure 2), intracerebellar injection of MND-GFP resulted in high
levels of GFP expression in cells throughout all layers of the
injected with CAG-FGF14B-IRES-tdTomato and immunostained for FGF14. Viral delivered FGF14 is properly localized at the Purkinje neuron AIS but
tdTomato expression is not visible. D. Schematic representation of CAG-FGF14B-P2A-GFP AAV transfer construct. The arrow represents approximate
location where ribosomal skipping should occur to generate two independent polypeptides. E. GFP expression in CHL1610 cells transfected with
CAG-FGF14B-GFP (top) or CAG-FGF14B-P2A-GFP (bottom). FGF14B-GFP fusion protein is expressed in punctate foci surrounding the nucleus whereas
FGF14B-P2A-GFP is expressed as a diffuse cytoplasmic protein, suggesting cleavage of GFP from FGF14B. F. Western blot analysis of P2A cleavage
efficiency in CHL cells. CHL1610 cells were transfected with either CAG-FGF14B-GFP or CAG-FGF14B-P2A-GFP and processed for western blot 24 h
after transfection. Immunoblotting for both FGF14 and GFP revealed a ,50kDa band in CAG-FGF14B-GFP transfected cells, which is consistent with
the expected size of the fusion protein. Immunoblotting for FGF14 and GFP in CAG-FGF14B-P2A-GFP transfected cells revealed ,25kDa bands for
FGF14 and GFP and no detectable,50kDa band, indicating efficient cleavage of the P2A peptide. G. Confocal image of Fgf142/2 cerebellum injected
with CAG-FGF14B-P2A-GFP and immunostained for FGF14 (red) and AnkyrinG (AnkG, blue). No GFP fluorescence is visible but viral delivered FGF14 is
properly expressed at the AIS of Purkinje neurons where it colocalizes with AnkyrinG. H. Confocal image of Fgf142/2 cerebellum injected with CAG-
FGF14B-P2A-GFP and immunostained for FGF14 (red) and GFP (blue). Immunostaining reveals that GFP is expressed and colocalizes with FGF14 in the
Purkinje neuron AIS, suggesting that P2A cleavage did not occur in vivo. Scale bars: 20 mm (B, E); 10 mm (C, G, H).
doi:10.1371/journal.pone.0104062.g006
Table 2. AIS expression of virally transduced FGF14 protein in Fgf142/2 Purkinje neurons.
Virus AnkyrinG AISc FGF14 AISc % Transduced
AAV1-FGF14B-IRES-tdTomatoa 14 13.7 97.9
AAV1-CAG-FGF14A-PGK-GFPb 8.1 7.9 97.5
aAverage of three 60x fields near injection site.
bAverage of nine 60x fields near injection site.
cImmunostaining (number of AIS stained/60x field).
doi:10.1371/journal.pone.0104062.t002
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cerebellar cortex, with particularly bright expression in cerebellar
white matter (Figure 3A, Table 1). Closer inspection of the
Purkinje layer revealed teardrop shaped GFP-negative spaces
(Figure 3B, asterisks), indicating an absence of GFP expression in
Purkinje neurons. Radial processes from MND-GFP-transduced
Bergmann glia were evident in the molecular layer (Figure 3B,
Table 1). The MSCV-GFP vector produced GFP expression
almost exclusively in Bergmann glia (Figure 2C and D, Table 1).
Venus expression driven by the UBC promoter was observed in
many small cells in the granule layer (Figure 3E and F, Table 1)
and in an occasional Purkinje neuron (Figure 3E and G). In one
animal injected with the PGK-GFP lentiviral vector several
Purkinje neurons were transduced (Figure 3H and J). However,
the cellular transduction pattern of PGK-GFP in a second animal
resembled the transduction pattern of the MND constructs, with
the vast majority of transduced cells located in the white matter
(Figure 3I, Table 1).
Intracerebellar injection technique does not affect
cellular transduction pattern by MND-tdTomato
lentivirus
The optimal dorsal-ventral injection depth for targeting
Purkinje neurons in vivo is quite shallow, due to the relatively
superficial location of Purkinje neuron somata. Intracerebellar
injections up to this point were performed by injecting virus
through a small burr hole in the cranium using a Hamilton syringe
and nanoinjector pump. To test whether injection technique
affected lentiviral cellular transduction patterns, a modified
injection technique was used in which a craniotomy was
performed to expose a small region of the dura, and MND-
tdTomato lentiviral particles were injected using a picospritzer
fitted with small diameter pulled glass pipettes (outer diameter of
18–25 mm, see methods). MND-tdTomato injected using this
technique transduced many cells throughout the cerebellar cortex
(Figure 4A). Similar to previous MND lentivirus injections using
the Hamilton syringe (Figures 2 and 3), transduced cells were
either white matter glial cells (Figure 4B) or Bergmann glia
(Figure 4C). No transduced Purkinje neurons were observed,
suggesting that injection technique does not affect viral transduc-
tion pattern.
AAV serotype 1 effectively transduces Purkinje neurons
and viral delivered FGF14 is properly localized
Because of very low Purkinje neuron transduction efficiency
using a variety of lentiviral vectors, an alternative viral vector was
sought. Previous reports suggested that adeno-associated viruses
(AAV) are capable of transducing Purkinje neurons in vivo [33–
35]. To assess Purkinje neuron transduction efficiency with AAV
vectors, an AAV, serotype 1 (AAV1) with a CAG (chicken b-actin
with CMV enhancer) promoter driving expression of EGFP
(CAG-GFP, Figure 5A) was injected directly into the cerebellum
of wild type mice. Three to four weeks following injection, sagittal
cerebellar sections were examined, and abundant Purkinje neuron
transduction was clearly evident with the CAG-GFP virus
(Figure 5B, Table 1).
Figure 7. AAV1 delivery of a dual promoter construct reveals that the CAG promoter produces better Purkinje neuron expression
than the PGK promoter. A. Schematic representation of the dual promoter AAV transfer construct which contains the CAG promoter followed by
FGF14A and the PGK promoter followed by GFP. CAG, chicken b-actin promoter containing the CMV enhancer; in, SV40 intron; PGK, human
phosphoglycerate kinase promoter; pA, polyadenylation site; ITR, inverted terminal repeat. B. Confocal images of sagittal sections from an Fgf142/2
mouse injected with the AAV-CAG-dual promoter virus and immunostained for FGF14 (red) and AnkyrinG (blue). Viral delivered FGF14 is properly
localized at the Purkinje neuron AIS where it colocalizes with AnkyrinG. A lower level of FGF14 expression is visible on the soma membrane. Viral
delivered GFP is expressed in small cells in the Purkinje layer that extend radial processes into the molecular layer (a pattern that is consistent with
Bergmann glia) but is clearly absent from Purkinje neurons. Scale bars: 25 mm (B, top); 5 mm (B, bottom).
doi:10.1371/journal.pone.0104062.g007
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To determine whether viral delivered transgenes were properly
targeted to subcellular domains, an AAV1 vector expressing a
Fibroblast Growth Factor 14 (FGF14) with carboxyl terminal GFP
fusion protein was generated (CAG-FGF14B-GFP, Figure 5A).
FGF14 is enriched at the axon initial segment (AIS) of wild-type
neurons [11,26,36], and addition of a GFP reporter gene to the
carboxyl terminus does not interfere with its function or
localization in vitro [26]. In murine cerebellum, FGF14 immu-
noreactivity has been reported in the Purkinje and granule layers
[10], with enrichment at the AIS of Purkinje neurons [11]. To
determine the expression pattern of viral delivered FGF14,
FGF14B-GFP-expressing virus was stereotactically injected into
the cerebellum of Fgf142/2 mice [17], and sagittal cerebellar
sections were immunostained with a monoclonal anti-FGF14
antibody (see methods). Consistent with previous reports in
Fgf142/2 cerebellum [10], no FGF14 immunostaining was visible
in Fgf142/2 cerebellum distal to the injection site (Figure 5C and
Figure 5D, top). In contrast, FGF14 immunoreactivity in Fgf142/
2 mice injected with FGF14B-GFP-expressing virus was evident in
an entire cerebellar lobe proximal to the injection site when
examined at low magnification (Figure 5C). Closer inspection of
the Purkinje and molecular layers proximal to the injection site
revealed FGF14 expression in the both the AIS and somata of
Purkinje neurons and the AIS of neurons in the molecular layer
(Figure 5D, middle, Table 1). For comparison, anti-FGF14
immunolabeling of a wild type, non-transduced cerebellar section
is included (Figure 5D, bottom), in which FGF14 expression is
evident in the granule layer, Purkinje neuron AIS, and AIS of
neurons in the molecular layer (Figure 5D, bottom left). In
addition, wild type FGF14 was also localized to the Purkinje
neuron soma membrane (Figure 5D, bottom right). No endoge-
nous fluorescence of viral-delivered FGF14B-GFP was detectable
(data not shown).
Lack of reporter gene fluorescence in Purkinje neurons
transduced with IRES and P2A containing viruses
Many studies would benefit from co-expression of multiple
heterologous proteins in neurons. For example, electrophysiolog-
ical studies of viral-transduced neurons require expression of a
fluorescent reporter gene for identification of transduced cells.
Figure 8. Co-injection of two AAV1-CAG viruses results in optimal Purkinje neuron expression of two different genes. A. Schematic
representation of the two AAV transfer constructs used for co-injection. AAV1-CAG-GFP and AAV1-CAG-FGF14B-IRES-tdTomato viruses were mixed
together at a ratio of 1:5 prior to injecting into Fgf142/2 cerebellum. CAG, chicken b-actin promoter with CMV enhancer; in, SV40 intron; IRES, internal
ribosome entry site; pA, polyadenylation site; ITR, inverted terminal repeat. B. Confocal images of sagittal sections from an Fgf142/2 cerebellum co-
injected with AAV1-CAG-GFP and AAV1-CAG-FGF14B-IRES-tdTomato and immunostained for FGF14 (red). GFP expression is readily visible in Purkinje
neuron somata and dendrites, and FGF14 is properly localized to the AIS. While some Purkinje neurons express FGF14 but not GFP, all GFP expressing
Purkinje neurons express FGF14. Scale bars: 25 mm (B, top); 5 mm (B, bottom).
doi:10.1371/journal.pone.0104062.g008
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Since GFP fluorescence in FGF14B-GFP expressing Purkinje
neurons was not visible without immunostaining, other strategies
to co-express a fluorescent reporter gene in Fgf142/2 Purkinje
neurons transduced with an FGF14-expressing virus were tested.
Figure 6A, illustrates an AAV transfer vector in which FGF14
expression is driven by the CAG promoter and tdTomato
expression is controlled by an internal ribosome entry site (IRES)
downstream from FGF14B. To verify expression of tdTomato in
the IRES context, CHL cells were transfected with CAG-
FGF14B-IRES-tdTomato plasmid DNA, and tdTomato fluores-
cence was examined 24 h after transfection. As shown in
Figure 6B, tdTomato was expressed in a cytoplasmic distribution
in these cells. To investigate the distribution of FGF14 and
tdTomato in transduced Purkinje neurons, FGF14B-IRES-tdTo-
mato-expressing AAV1 virus was stereotactically injected into
Fgf142/2 cerebellum, and sagittal cerebellar sections were
immunostained for FGF14. Consistent with findings from
FGF14B-GFP transduced Purkinje neurons (Figure 5), FGF14
immunolabeling was present at the AIS of FGF14B-IRES-
tdTomato-transduced Purkinje neurons (Figure 6C, Table 1).
Surprisingly, however, tdTomato fluorescence was not detectable
(Figure 6C). In regions near the injection site, 97.9% of Purkinje
neurons were transduced with the FGF14B-IRES-tdTomato virus,
as demonstrated by the number of anti-FGF14 positive Purkinje
neuron AIS relative to the number of anti-AnkyrinG positive
Purkinje neuron AIS (Table 2).
2A sequences have been shown to mediate cleavage between
two protein coding sequences via a ribosomal skip mechanism [9],
and have been used in viral vectors to coordinate expression of two
genes in neurons [4,37,38]. An AAV-CAG vector in which
FGF14B was separated from GFP by a P2A (porcine-teschovirus-
1) peptide coding sequence [27] was generated (Figure 6D). To
verify fluorescence of GFP and P2A-mediated cleavage of FGF14
from GFP, the FGF14B-P2A-GFP or FGF14B-GFP (fusion)
constructs (Figure 6D and 5A) were transfected into CHL1610
cells, and 24 h following transfection, cells were examined for GFP
fluorescence (Figure 6E). Similar to previous reports in NIH3T3
cells [39], GFP expression in cells transfected with FGF14B-GFP
plasmid was excluded from the nucleus and present in discrete
punctae adjacent to the nucleus (Figure 6E, top). In contrast, in
cells transfected with FGF14B-P2A-GFP, GFP expression was
localized throughout the cytoplasm (Figure 6E, bottom). A similar
GFP expression pattern was seen in cells transduced with virus
expressing FGF14-P2A-GFP (data not shown). Following analysis
of GFP expression, cells were immediately processed for Western
blot analysis, and membranes were probed with anti-GFP or anti-
FGF14 specific antibodies. Consistent with previous Western blot
studies of FGF14B-GFP [36], immunoblotting of protein extracts
from FGF14B-GFP transfected cells revealed a ,50 kDa band
when probed with the anti-GFP antibody (Figure 6F, bottom), the
expected size for an FGF14B-GFP fusion protein. A ,50 kDa
band was also present in FGF14B-GFP extracts probed with the
anti-FGF14 antibody (Figure 6F, top), indicating that the
FGF14B-GFP fusion protein is detectable with both anti-GFP
and anti-FGF14 antibodies. In stark contrast, a ,25 kDa band
was present in FGF14B-P2A-GFP extracts probed with either the
anti-GFP antibody (Figure 6F, bottom) or the anti-FGF14
antibody (Figure 6F, top). No ,50 kDa band representing
FGF14B-GFP fusion protein product was evident in the
FGF14B-P2A-GFP cell extracts when probed with either antibody
(Figure 6F), indicating that the P2A-mediated cleavage was
efficient in CHL cells.
To examine localization and cleavage of FGF14-P2A-GFP in
Purkinje neurons, FGF14B-P2A-GFP-expressing virus was stereo-
tactically injected into Fgf142/2 mouse cerebellum, and sagittal
cerebellar sections were immunostained with anti-FGF14 and
anti-AnkyrinG-specific antibodies. Similar to previous reports in
wild type neurons [40], AnkyrinG localized to the AIS in
Fgf142/2 Purkinje neurons (Figure 6G). Transduced Purkinje
neurons were identified by FGF14 immunolabeling, which was
present in the Purkinje neuron soma and AIS (Figure 6G,
Table 1). Unexpectedly, no GFP fluorescence was visible
(Figure 6G), despite the fact that an AAV-GFP virus containing
the same GFP coding sequence produced robust GFP expres-
sion in Purkinje neurons (Figure 5B). To determine if GFP
protein was synthesized in these cells, sagittal cerebellar sections
from brains injected with FGF14B-P2A-GFP were immuno-
stained with anti-FGF14 and anti-GFP antibodies (Figure 6H).
Transduced Purkinje neurons were identified by anti-FGF14
immunolabeling (Figure 6H). Surprisingly, while no direct GFP
fluorescence was visible, the presence of GFP protein was
confirmed by anti-GFP immunolabeling (Figure 6H). Moreover,
the subcellular localization of FGF14 and GFP immunolabeling
was identical (Figure 6H), consistent with a failure of P2A-
mediated cleavage in murine Purkinje neurons in situ and loss
of fluorescent properties of the non-cleaved FGF14-P2A-GFP
fusion protein.
Transgene expression in cerebellar cells transduced with
dual-promoter AAV virus
Viral vectors with dual promoters have also been used to
drive expression of separate transgenes in neurons [5]. To
determine whether FGF14 and GFP could be co-expressed in
the same Purkinje neuron using a dual promoter vector, an
AAV construct was generated in which FGF14A expression was
controlled by the CAG promoter and GFP was controlled by the
PGK promoter (Figure 7A). The PGK promoter was chosen for
the second promoter because GFP was expressed in some
Purkinje neurons when driven by the PGK promoter in a
lentiviral construct (Figure 3H–J). Fgf142/2 mice cerebella
were stereotaxically injected with CAG-FGF14A-PGK-GFP-
expressing AAV1 virus, and cerebella were examined for GFP
and FGF14 expression three to four weeks after injection by
immunostaining sagittal sections with anti-FGF14 and anti-
AnkyrinG antibodies. Similar to other FGF14 expressing
viruses, transduction with CAG-FGF14A-PGK-GFP-expressing
virus resulted in FGF14 immunolabeling in the Purkinje neuron
AIS, where it colocalized with AnkryinG (Figure 7B, Table 1).
FGF14 immunolocalization was not, however, found in the
cytoplasm of the Purkinje neuron soma but was observed at the
Purkinje neuron soma membrane, albeit at a lower level than at
the AIS (Figure 7B). In regions near the injection site, 97.5% of
Purkinje neurons were transduced with the CAG-FGF14A-
PGK-GFP virus, as demonstrated by the number of anti-FGF14
positive Purkinje neuron AIS relative to the number of anti-
AnkyrinG positive Purkinje neuron AIS (Table 2). Surprisingly,
GFP expression was not present in Purkinje neurons but instead
was robustly expressed in small cells in the Purkinje layer that
extend radial processes into the molecular layer, a pattern that is
consistent with Bergmann glia (Figure 7B), even though
Purkinje neurons were clearly transduced, as evidenced by
FGF14 immunolabeling. Conversely, no FGF14 expression was
apparent in Bergmann glia, despite the fact that Bergmann glia
were also clearly transduced with CAG-FGF14-PGK-GFP
expressing virus (Figure 7B).
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Co-injection of two AAV1-CAG viruses allows expression
of transgene and fluorescent reporter gene in the same
Purkinje neuron
Co-injection of two viruses expressing different genetic sequenc-
es has been used to co-express multiple transgenes in the same cell
[6]. To determine whether FGF14 and GFP could be co-expressed
in the same Purkinje neuron when delivered by separate viruses,
separate AAV1-CAG viruses expressing either FGF14B-IRES-
tdTomato or GFP were used (Figure 8A). To increase the
likelihood that a given cell expressing GFP would also express
FGF14, viruses were mixed in a 5:1 (FGF14:GFP) ratio and then
stereotactically co-injected into Fgf142/2 cerebellum. Three to
four weeks post-injection, sagittal cerebellar sections were immu-
nostained with an FGF14-specific antibody. Consistent with
previous findings in cerebella injected with a single virus
(Figure 5B and 6C), GFP was expressed throughout the cytoplasm
of many Purkinje neurons, and FGF14 was expressed in both the
cytoplasm and AIS of Purkinje neurons (Figure 8B). Neurons in
the molecular layer (stellate and basket cells) also expressed FGF14
at the AIS (Figure 8B). Multiple Purkinje neurons expressing both
GFP and FGF14 were evident (Figure 8B). Whereas some
Purkinje neurons expressing FGF14 alone were present, no
neurons expressing GFP alone could be identified (Figure 8B,
bottom), which was consistent with the relative amounts of each
virus in the co-injection mix.
Discussion
We have compared gene delivery to mature murine Purkinje
neurons in vivo using AAV1 or lentiviral vectors with various
promoter combinations and optimized for expression of two
proteins in the same Purkinje neuron. Expression of fluorescent
reporter proteins in lentiviral vectors appeared to be highly
promoter dependent, since MND and MSCV promoters pro-
duced almost exclusively glial cell expression patterns, whereas the
UBC promoter expressed well in granule neurons, and the PGK
promoter appeared to express in glial cells and Purkinje neurons.
Because of the low Purkinje neuron transduction efficiency using
lentiviral vectors, we switched to an AAV vector and fortuitously
obtained excellent Purkinje neuron transduction with the first
AAV vector tested, AAV1 with the CAG promoter.
Subsequent experiments designed to co-express two proteins in
the same Purkinje neuron with an IRES sequence, P2A sequence,
or dual promoters were unsuccessful, but we showed that two
AAV1-CAG viruses were capable of efficiently transducing and
expressing different transgenes in the same Purkinje neuron when
co-injected. The results of this study will be useful for future studies
of Purkinje neuron physiology, which require genetic manipula-
tion of mature cells in vivo.
Transduction of cerebellar cells in vivo with lentivirus has been
reported by other groups. Intracerebellar injection of lentivirus
with a ubiquitous promoter from cytomegalovirus (CMV) and
VSV-G envelop protein transduced a wide range of cerebellar cells
including glia and Purkinje, stellate, and golgi neurons [41]. A
recombinant feline immunodeficiency virus (FIV) containing a
CMV promoter transduced Purkinje neurons and stellate and
basket neurons in the molecular layer but few glia cells [33].
Takayama and colleagues compared VSV-G pseudotyped, HIV-
derived lentiviral vectors containing promoters from MSCV,
CMV, CAG, or Rous sarcoma virus (RSV), and found that the
MSCV promoter produced the most efficient transduction of
Purkinje neurons [42,43]. In stark contrast, our study showed that
VSV-G pseudotyped lentivirus with MSCV promoter was
expressed almost exclusively in Bergmann glia. It has been
reported that transduction efficiency of lentivirus with MSCV
promoter shifted from Purkinje neurons to Bergmann glia when
viruses were exposed to lower pH during harvest from packaging
cells, and it was speculated that lower pH activates a proteolytic
mechanism which alters the VSV-G envelop protein and cellular
tropism [44]. Recently, Goenawan and Hirai reported that
addition of Cathepsin K inhibitor to the lentiviral culture media
modulated lentiviral tropism for Purkinje neurons [45]. It is
possible that alterations in our lentiviral production technique
could increase Purkinje neuron transduction efficiency. However,
the fact that all of our lentiviruses were harvested using the same
protocol but expression patterns varied depending on promoter,
argues for a promoter-dependent mechanism for preferential
Purkinje neuron expression. Indeed, a multitude of studies have
shown that choice of promoter is critical to obtain cell-specific
expression with VSV-G pseudotyped lentivirus [42,46–49].
We also explored the impact of injection technique on Purkinje
neuron transduction efficiency. Lenviral injections performed
using a Hamilton syringe and nanoinjector pump produced a
similar transduction pattern as injections performed using small
diameter pulled glass pipettes and a picospritzer, suggesting that
injection technique does not significantly affect Purkinje neuron
transduction efficiency. In contrast, depth of injection may alter
transduction pattern. Dodge et al reported that injection of various
AAV serotypes into the deep cerebellar nuclei (DCN) of adult mice
yielded widespread transduction of cells throughout the cerebel-
lum, brain stem, midbrain, and spinal cord [50]. Another study
found that AAV2 injected into either the DCN or cerebellar cortex
transduced substantial numbers of Purkinje neurons, but that
more Purkinje neurons were transduced with injections into the
cerebellar cortex [34]. We did not test DCN injections under our
conditions, but because our goal was to selectively transduce
Purkinje neurons (versus neurons in other brain regions),
cerebellar cortical injections were likely appropriate.
The relative contribution of vector promoter versus virus type
or AAV serotype to Purkinje neuron specificity is unclear and
difficult to assess. In our study, intracerebellar injection of AAV1
containing the CAG promoter produced transgene expression in
many Purkinje neurons but also in some stellate and basket cell
interneurons in the molecular layer. In a previous study, AAV5
containing the Rous sarcoma virus (RSV) promoter was found to
produce transgene expression in Purkinje, stellate, and basket
neurons and in a few glial cells [33]. In comparison, lentiviral
particles containing the RSV promoter transduced a high
percentage of glial cells but very few Purkinje neurons [42].
Kaemmerer et al. reported that AAV2 containing CMV promoter
only transduced Purkinje neurons if it was co-injected with
adenovirus 5 (Ad5) as a helper virus, whereas AAV2 containing
the CAG promoter was highly effective at transducing Purkinje
neurons [34], suggesting that the CAG promoter is perhaps more
specific for Purkinje neurons than the CMV promoter. However,
lentiviruses containing the CAG promoter were not specific for
Purkinje neurons [42]. In contrast, the CMV promoter contained
in an AAV1 vector appeared to be highly specific for Purkinje
neurons, at least when viewed at low magnification [35]. CMV
promoter-containing lentiviruses, either derived from HIV [42] or
FIV [33], were not specific for Purkinje neurons, and while the
HIV-derived lentiviruses transduced many glial cells [42], the FIV-
derived lentiviruses transduced mainly neurons [33]. Cell specific
expression is likely a combined result of viral particle interaction
with host cell-surface factors in addition to the activity of the
promoter in a given cell type. Determining the relative contribu-
tions of viral tropism versus promoter activity to gene expression
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following injection of virus into the cerebellum would require a
careful analysis of each factor.
In our in vivo experiments, the FGF14B-GFP fusion protein
failed to fluoresce, in contrast to its fluorescence in heterologous
cells and in cultured hippocampal neurons [26,36]. In addition,
the FGF14B-P2A-GFP virus, which we hypothesize to have also
produced an FGF14B-GFP fusion protein, also failed to fluoresce
in vivo. It is clear that the message and protein is being made at a
reasonable level, since the protein is detectable by antibody
staining. One possible explanation for lack of endogenous GFP
fluorescence could be that localization at the AIS masks the
endogenous fluorescence, possibly due to interactions with other
proteins.
Our results using the dual promoter AAV1 virus, in which PGK
drives expression of GFP and CAG drives expression of FGF14,
indicate that AAV1 does transduce both glia and neurons, but that
neuronal expression is dependent on the promoter, since PGK
drives expression mainly in Bergmann glia whereas CAG drives
expression mostly in Purkinje neurons. Both cell types (neurons
and glia) were clearly transduced by the same dual promoter virus,
so it is unclear why dissociated gene expression was observed. One
possibility is that the PGK promoter is less active in neurons;
however, our study using lentivirus containing the PGK promoter
indicated that PGK could, in fact, drive expression in Purkinje
neurons. Another possibility is that the CAG promoter suppressed
PGK promoter expression in Purkinje neurons by a transcriptional
interference or promoter competition mechanism [51,52]. As an
alternative to using different promoters to drive expression of each
transgene, we could have used two CAG promoters in tandem.
We chose not to do so to avoid the potential problem of DNA
recombination, either in viral packaging cells or in transduced
cells. However, it is possible that we could have achieved co-
expression of FGF14 and GFP using this strategy.
IRES sequences have been used for multiple gene expression in
CNS neurons; however, in many instances, only the first gene is
expressed strongly and IRES-dependent translation is much
weaker [53]. In our hands, IRES-dependent tdTomato fluores-
cence was undetectable in vivo, even though it was robustly
expressed in vitro. Other groups have also reported instances in
which fluorescence of the second, IRES-dependent gene was
undetectable [54]. Furthermore, the efficiency of IRES-dependent
translation has been shown to vary in different cell types [55].
Thus, it is possible that IRES sequences are simply less efficient in
Purkinje neurons; however, other groups have reported co-
expression of two genes in murine Purkinje neurons using IRES
sequences[56]. Further experimentation, such as antibody stain-
ing, would be required to determine whether tdTomato protein
was expressed in cells transduced with our IRES-tdTomato virus.
Another method for expressing multiple proteins from a single
promoter is to use 2A sequences inserted between the coding
regions for each protein. 2A sequences, which induce cleavage by
a ribosomal skip mechanism [9], function in all eukaryotic systems
tested to date, and have become popular due to their small size
and yield of essentially equimolar quantities of each protein
product [8]. In the present study, we used a 2A sequence from
porcine teschovirus (P2A), which was reported to produce the
highest cleavage efficiency compared to other 2A sequences in
multiple mammalian cell types, including mouse liver in vivo [27].
P2A sequences have also been used in lentiviral vectors to express
multiple proteins in rat Purkinje neurons [57]. In our hands, P2A-
mediated cleavage between FGF14 and GFP was quite efficient in
CHL cells; however, there was no apparent cleavage in Purkinje
neurons in vivo, as suggested by the exact co-localization of the
FGF14 and GFP immunostaining at the AIS. A possible
explanation for lack of cleavage could be that the P2A nucleotide
sequence we used [27], differs slightly from the P2A sequence used
by Ohashi and colleagues [57], although the resultant peptide
sequences are identical. However, since 2A-mediated cleavage is
thought to be a co-translational process in which a peptide bond is
‘‘skipped’’ between the Gly and Pro in the 2A motif (D(V/
I)EXNPGP), most of the peptide sequence would have already
been generated by the time the skipped peptide bond was reached,
and it is unlikely that any small changes in nucleotide sequence
would have made a difference. Other studies have shown that
certain peptide sequences upstream of 2A may prevent cleavage
[58,59]. In particular, failure of 2A-mediated cleavage resulted
when some secreted proteins [59] or proteins targeted to the
endoplasmic reticulum (ER) [58] were placed upstream of the 2A
sequence. We placed FGF14 upstream of P2A in our vector, and
while FGF14 (a non-secreted protein) is cytoplasmic in HEK293
cells [39], in neurons it appeared to be localized to the membrane
of the soma and AIS. Whether FGF14 is processed in the ER is
unknown, but inhibition of 2A-mediated cleavage in neurons
could be due to neuron-specific membrane trafficking of FGF14.
Reversing the order of transgenes relative to the 2A sequence may
overcome the inhibition of 2A-mediated cleavage. Other studies
have indicated that placing a flexible Gly-Ser-Gly spacer, furin
proteinase cleavage site, or amino acids from protein 1D
immediately upstream of the 2A sequence improves cleavage
efficiency [60–62]. Placing tandem 2A sequences between the two
transgenes may also improve cleavage efficiency. We did include
the Gly-Ser-Gly spacer in our construct, but we have not tested the
efficacy of other spacers.
In conclusion, we have demonstrated that murine Purkinje
neurons can be transduced by AAV1 vectors containing CAG
promoters, and that co-injection of two CAG containing AAV1
viruses results in co-expression of two transgenes in many Purkinje
neurons. The failure of many of our attempts to co-express two
transgenes in Purkinje neurons highlights the importance of
examining trangenes and delivery methods in the cellular context
in which they will be used.
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